Press release
Venous Stents Market: Demand Forecast, Trends, and Future Outlook (2034)
The Venous Stents Market is witnessing significant growth, driven by the rising prevalence of venous diseases and advancements in medical technology. Valued at USD 1.10 billion in 2024, the market is projected to expand at a CAGR of 8.45%, reaching USD 2.48 billion by 2034.Get a free sample report: https://shorturl.at/rGGyt
Overview of the Venous Stents Market
Venous stents are medical devices used to treat venous obstructions, ensuring proper blood flow in patients with conditions like deep vein thrombosis (DVT) and chronic venous insufficiency. The increasing incidence of these conditions, coupled with the aging population and sedentary lifestyles, has amplified the demand for venous stents globally.
Market Size and Share Analysis
The global venous stents market, valued at USD 1.10 billion in 2024, is anticipated to reach USD 2.48 billion by 2034, growing at a CAGR of 8.45%. North America holds a significant market share, attributed to advanced healthcare infrastructure and high adoption rates of innovative medical devices. Europe follows closely, with a projected CAGR of 10.3% during the forecast period.
Market Dynamics and Trends
Drivers:
Rising Prevalence of Venous Diseases: An increase in conditions like DVT and post-thrombotic syndrome has heightened the demand for effective treatment options, including venous stents.
Technological Advancements: Innovations in stent design and materials have improved patient outcomes, encouraging adoption among healthcare providers.
Trends:
Minimally Invasive Procedures: The shift towards less invasive treatments has bolstered the use of venous stents, offering quicker recovery times and reduced hospital stays.
Outpatient Surgeries: The growing preference for outpatient procedures has increased the demand for devices that facilitate such treatments, including venous stents.
Read full report with table of content: https://shorturl.at/SBooc
Growth Opportunities and Challenges
Opportunities:
Emerging Markets: Developing regions present untapped potential due to increasing healthcare investments and awareness.
Product Innovation: Continuous research and development can lead to more efficient and patient-friendly stent designs.
Challenges:
Regulatory Hurdles: Stringent approval processes can delay product launches and market entry.
High Costs: The expense associated with advanced stent technologies may limit accessibility in cost-sensitive markets.
Recent Developments
Inari Medical Acquisition: In a strategic move, Stryker announced a $4.9 billion acquisition of Inari Medical, aiming to enhance its portfolio in venous thromboembolism treatments.
Becton Dickinson's Expansion: Becton Dickinson reported higher-than-expected profits, driven by robust demand for its medical devices, and announced the acquisition of Edwards Lifesciences' critical care products unit for $4.2 billion.
Competitive Landscape
The venous stents market is characterized by the presence of several key players:
Abbott Laboratories
Becton, Dickinson and Company
Bentley
Boston Scientific Corporation
Cardinal Health
Cook Group Incorporated
Koninklijke Philips N.V.
Medtronic
W.L Gore & Associates, Inc.
Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd.
Jotec GmbH
Optimed Medizinische Instrumente GmbH
MicroPort Scientific Corporation
Medica Germany GMBH & Co.KG
Cordis Inc.
These companies are focusing on strategic collaborations, product innovations, and expanding their global footprint to strengthen their market position.
Frequently Asked Questions (FAQs)
What are venous stents?
Venous stents are tubular devices inserted into veins to keep them open, ensuring proper blood flow in conditions like DVT and chronic venous insufficiency.
What factors are driving the venous stents market growth?
The market growth is driven by the increasing prevalence of venous diseases, technological advancements in stent design, and a shift towards minimally invasive procedures.
Which regions are leading in the venous stents market?
North America currently leads the market, followed by Europe and the Asia-Pacific region, which is expected to witness significant growth due to rising healthcare investments.
Who are the major players in the venous stents market?
Key players include Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Medtronic, and Cook Group Incorporated, among others.
The Venous Stents Market is poised for substantial growth, fueled by the rising incidence of venous diseases and continuous technological advancements. While challenges like regulatory hurdles and high costs persist, the market offers significant opportunities, especially in emerging economies. Strategic initiatives by key players and a focus on innovation are expected to drive the market forward in the coming years.
Find More Blog:
Juvenile Macular Degeneration (JMD) Drug Pipeline Analysis Report: https://rb.gy/yenpci
Gastric Neuroendocrine Tumors Drug Pipeline Analysis: https://rb.gy/js5wzq
Human Immunodeficiency Virus (HIV 1) Infection Drug Pipeline Analysis: https://shorturl.at/jqqPe
Acute Pain Drug Pipeline Analysis: https://shorturl.at/k3Uvz
Treatment Resistant Depression Drug Pipeline Analysis: https://shorturl.at/dGA3L
Media Contact:
Company Name: Claight Corporation
Contact Person: Deepanshu Choudhary, Digital Marketing
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others. Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Venous Stents Market: Demand Forecast, Trends, and Future Outlook (2034) here
News-ID: 4051768 • Views: …
More Releases from Expert Market Research
IT Spending Market Outlook 2026-2035: Growth Drivers and Future Trends
The global IT spending market continues to expand steadily as enterprises across industries accelerate digital transformation, cloud migration, and artificial intelligence adoption. In 2025, the IT spending market attained a total value of USD 4.02 Trillion, reflecting strong global demand for software, IT services, cloud infrastructure, and communications technologies. The industry is expected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period of 2026-2035,…
United States School Bus Market Size, Share & Forecast 2026-2035
The United States school bus market is a crucial component of the country's transportation infrastructure, ensuring the safe and reliable transport of millions of students each day. With a history of being a significant mode of student transportation, school buses are now evolving with advancements in technology, safety, and environmental standards. As the demand for greener solutions and enhanced safety features grows, the U.S. school bus market is expanding to…
Cosmetics Market Outlook 2026-2035: Growth, Trends, Segmentation, and Regional A …
The global cosmetics market continues to demonstrate robust growth, driven by evolving consumer preferences, rising awareness of health and wellness, and rapid advancements in digital commerce. In 2025, the cosmetics market attained a value of USD 361.23 Billion, reflecting strong demand across both developed and emerging economies. Looking ahead, the market is projected to grow at a compound annual growth rate (CAGR) of 5.20% from 2026 to 2035, reaching an…
Global Steel Market Outlook: Growth Projections for 2026-2035
The global steel market continues to play a crucial role in the world's industrial landscape, driven by increasing demand in various sectors such as construction, automotive, and infrastructure. As the global economy recovers and modernizes, the steel market is expected to see steady growth in the coming decade. This blog explores the key trends, drivers, and projections for the steel market from 2026 to 2035.
Market Overview
In 2025, the global steel…
More Releases for Venous
Key Trends Reshaping the Chronic Venous Occlusions Treatment Market: Introductio …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Chronic Venous Occlusions Treatment Market Size Growth Forecast: What to Expect by 2025?
The market dedicated to therapies for chronic venous occlusions has experienced robust expansion lately, projected to increase from a valuation of $6.7 billion in 2024 to $7.15 billion the following year, reflecting a consistent compound annual…
States Venous Stents Market Projected to Witness Expansion with Rising Incidence …
States Venous Stents Market Overview
The States Venous Stents Market is expected to grow from USD 1.3 billion in 2025 to USD 2.4 billion by 2032, registering a CAGR of 8.9%.
Coherent Market Insights is pleased to release its latest States Venous Stents Market research report, offering an in-depth analysis of the U.S. States Venous Stents Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,…
Venous Stent Market Grows with Rising Cases of Chronic Venous Disorders | Boston …
Venous Stent Market Overview
The venous stent market is anticipated to grow from USD 0.6 billion in 2025 to USD 1.3 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period.
Coherent Market Insights is proud to announce the release of its latest market research report, providing a comprehensive analysis of the Venous Stent Market Landscape from 2025 to 2032. This report delivers precise forecasts across global, regional, and country…
Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infr …
How Will the Venous Thromboembolism Market Grow, and What Is the Projected Market Size?
Over the past few years, the venous thromboembolism market has experienced a steady increase in its size. It's projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.4%. The growth during the historic period can be credited to an increasing elderly population, progress in…
Venous Catheter Market Size 2024 to 2031.
Market Overview and Report Coverage
A venous catheter is a small, flexible tube inserted into a vein for medical purposes such as accessing the bloodstream for medications, fluids, or blood sampling. The venous catheter market is expected to witness significant growth in the coming years, with a projected CAGR of 6.30% during the forecasted period.
The current outlook for the venous catheter market is positive, driven by factors such as…
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism.
Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188
Pulmonary embolism occurs in almost one-third of patients…
